Disposition Index, Glucose Effectiveness, and Conversion to Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Disposition index (DI) and glucose effectiveness (S(G)) are risk factors for diabetes. However, the effect of DI and S(G) on future diabetes has not been examined in large epidemiological studies using direct measures. RESEARCH DESIGN AND METHODS: Insulin sensitivity index (S(I)), acute insulin response (AIR), and S(G) were measured in 826 participants (aged 40-69 years) in the Insulin Resistance Atherosclerosis Study (IRAS) by the frequently sampled intravenous glucose tolerance test. DI was expressed as S(I) x AIR. At the 5-year follow-up examination, 128 individuals (15.5%) had developed diabetes. RESULTS: The area under the receiver operating characteristic curve of a model with S(I) and AIR was similar to that of DI (0.767 vs. 0.774, P = 0.543). In a multivariate logistic regression model that included both DI and S(G), conversion to diabetes was predicted by both S(G) (odds ratio x 1 SD, 0.61 [0.47-0.80]) and DI (0.68 [0.54-0.85]) after adjusting for demographic variables, fasting and 2-h glucose concentrations, family history of diabetes, and measures of obesity. Age, sex, race/ethnicity, glucose tolerance status, obesity, and family history of diabetes did not have a significant modifying impact on the relation of S(G) and DI to incident diabetes. CONCLUSIONS: The predictive power of DI is comparable to that of its components, S(I) and AIR. S(G) and DI independently predict conversion to diabetes similarly across race/ethnic groups, varying states of glucose tolerance, family history of diabetes, and obesity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whereas children and adults with a low disposition index are most likely to progress to type 2 diabetes (19,34–38).”
From Hyperglycemia and Adverse Pregnancy Outcome Follow-up Study (HAPO FUS): Maternal Glycemia and Childhood Glucose Metabolism (2019) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kahn, S. E., Prigeon, R. L., McCulloch, D. K., Boyko, E. J., Bergman, R. N., Schwartz, M. W., Neifing, J. L., Ward, W. K., Beard, J. C., & Palmer, J. P. (1993) · Diabetes · doi:10.2337/diab.42.11.1663 · Cited by 1,405 · cited 2×
“Firstphase insulin secretion compensates for the worsening of insulin sensitivity (2).”
Self-citationMartin, B. C., Warram, J. H., Krolewski, A. S., Soeldner, J. S., Kahn, C. R., Martin, B. C., & Bergman, R. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92814-v · Cited by 1,158 · cited 2×
“Although reduced in individuals with impaired glucose tolerance (IGT) and diabetes (4,13), SG contributes to glucose tolerance even in conditions of significant insulin resistance, including diabetes (13).”
Self-citationAssessment of Insulin Sensitivity in Vivo*
Bergman, R. N., Finegood, D. T., & Ader, M. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-1-45 · Cited by 1,066
Self-citationUtzschneider, K. M., Prigeon, R. L., Faulenbach, M. V., Tong, J., Carr, D. B., Boyko, E. J., Leonetti, D. L., McNeely, M. J., Fujimoto, W. Y., & Kahn, S. E. (2009) · Diabetes Care · doi:10.2337/dc08-1478 · Cited by 572
The Insulin Resistance Atherosclerosis Study (IRAS)
Wagenknecht, L. E., Mayer, E. J., Rewers, M., Haffner, S., Selby, J., Borok, G. M., Henkin, L., Howard, G., Savage, P. J., Saad, M. F., et al. (1995) · Annals of Epidemiology · doi:10.1016/1047-2797(95)00062-3 · Cited by 492 · cited 2×
“To meet these aims, we used data from the Insulin Resistance Atherosclerosis Study (IRAS), a multicenter observational epidemiological study of different ethnic groups and varying states of glucose tolerance (19).”
Self-citationWELCH, S., GEBHART, S. S. P., BERGMAN, R. N., & PHILLIPS, L. S. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-6-1508 · Cited by 337 · cited 2×
“0 [1994], Los Angeles, California, courtesy of Richard Bergman, PhD) (21).”
InfluentialSelf-citationEvaluation of proposed oral disposition index measures in relation to the actual disposition index
Retnakaran, R., Qi, Y., Goran, M. I., & Hamilton, J. K. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02841.x · Cited by 320 · cited 1×
“This product has been shown to have a modest correlation with minimal model–derived DI, to decrease as glucose tolerance status deteriorates, and to predict the development of diabetes independent of other risk factors including fasting and 2-h glucose concentrations (7,8).”
Role of Glucose Effectiveness in the Determination of Glucose Tolerance
Best, J. D., Kahn, S. E., Ader, M., Watanabe, R. M., Ni, T. C., & Bergman, R. N. (1996) · Diabetes Care · doi:10.2337/diacare.19.9.1018 · Cited by 290 · cited 1×
“Although reduced in individuals with impaired glucose tolerance (IGT) and diabetes (4,13), SG contributes to glucose tolerance even in conditions of significant insulin resistance, including diabetes (13).”
Self-citationThe Natural Course of β-Cell Function in Nondiabetic and Diabetic Individuals
Festa, A., Williams, K., D’Agostino, R., Wagenknecht, L. E., & Haffner, S. M. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1100 · Cited by 271 · cited 1×
“In studies using direct methods, such as the frequently sampled intravenous glucose tolerance test (FSIGTT) with minimal model analysis, this relationship is hyperbolic (2) and similar across glucose tolerance categories (3).”
Self-citationBeta cell function and its relation to insulin action in humans: a critical appraisal
Ferrannini, E., & Mari, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1381-z · Cited by 262 · cited 2×
“The hyperbolic paradigm of the minimal model–derived DI has also been criticized (10).”
Cited by
Items 101–142 of 142
Omar, B. A., Pacini, G., & Åhrén, B. (2014) · Physiological Reports · doi:10.14814/phy2.12011 · Cited by 5
“The use of IVGTT has therefore been of value to evaluate b-cell function in various degrees of insulin resistance, such as comparing normal weight and obese individuals (Lorenzo et al. 2010).”
Palmer, N. D., Wagenknecht, L. E., Langefeld, C. D., Wang, N., Buchanan, T. A., Xiang, A. H., Allayee, H., Bergman, R. N., Raffel, L. J., Chen, Y.-D. I., et al. (2016) · Diabetes · doi:10.2337/db15-1543 · Cited by 5
“Seven variants were significantly associated with DI, which is thought to be a good predictor of diabetes onset (35) taking into account the contributions of both insulin sensitivity and response, SI and AIRg, respectively.”
Self-citationBeaudry, M., Bissonnette, S., Lamantia, V., Devaux, M., & Faraj, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076130 · Cited by 5
“A lower IS combined with insufficient ISec, measured as a lower disposition index, was reported to be an independent predictor of the conversion of prediabetes to T2D across many ethnic groups and races [2].”
Dorcely, B., de Bermont, J., Gujral, A., Reid, M., Vanegas, S. M., Popp, C. J., Verano, M., Jay, M. R., Schmidt, A. M., Bergman, M., et al. (2024) · Obesity Science & Practice · doi:10.1002/osp4.729 · Cited by 5
“38 Consistent with a previous study, this study shows that metabolic and bariatric surgery improves disposition index.”
Estimation of the disposition index based on components of metabolic syndrome
Lin, J., Hsieh, C. H., Liu, C. C., Lian, W., Wu, C., Hsu, C., Pei, D., Hsia, T., & Chen, Y. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0510 · Cited by 5
“At the same time, DI is a well-known predictor of T2DM [5].”
Insulin Sensitivity After Living Donor Nephrectomy
Tanrıöver, B., Lingvay, I., Ahmed, F. S., Sandıkçı, B., Mohan, S., Cremers, S., Karmally, W., Mohan, P., Newhouse, J. H., Ragunathan, S., et al. (2021) · Transplantation Proceedings · doi:10.1016/j.transproceed.2021.06.007 · Cited by 5
Hari, A., Fealy, C. E., Solomon, T. P. J., Haus, J. M., Kelly, K. R., Barkoukis, H. D., & Kirwan, J. P. (2019) · Acta Diabetologica · doi:10.1007/s00592-018-1272-2 · Cited by 8
Pathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity
Weiss, R., & Hagman, E. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_23 · Cited by 6
van den Brink, W. J., van den Broek, T. J., Wopereis, S., Difrancesco, S., van der Horst, F. A. L., & de Hoogh, I. M. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108188 · Cited by 6
Shan, C., Yu, J., Zhu, Y., Zhao, J., Wang, L., Li, Y.-S., Lin, S.-Y., Liu, W., Lü, Q., & Tao, T. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf272 · Cited by 4
Pathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity
Weiss, R., Cali, A. M. G., & Caprio, S. (2010) · Springer eBooks · doi:10.1007/978-1-60327-874-4_13 · Cited by 5
Effects of Roux-en-Y Gastric Bypass on β-Cell Function
Weiss, R. (2014) · Diabetes · doi:10.2337/db13-1897 · Cited by 5
Serum lipid profile as a tool to predict incident diabetes: Is it a wishful thinking?
Young, K. A., & Rasouli, N. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107755 · Cited by 4
Dietrich, J. W., Abood, A., Dasgupta, R., Anoop, S., Jebasingh, F., Spurgeon, R., Thomas, N., & Boehm, B. O. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.13525 · Cited by 6
Sola, D., Bellan, M., Mai, S., Minisini, R., Perazzi, M., Brunani, A., Gentilli, S., Sainaghi, P. P., Scacchi, M., & Marzullo, P. (2024) · Medical Science Monitor · doi:10.12659/msm.944462 · Cited by 3
“The following validated index were derived: HOMA-IR [24], insulin sensitivity index according to Matsuda [25], insulinogen-ic index [26], and disposition index [27].”
Mechanisms of improved glucose handling after metabolic surgery: the big 6
Paszkiewicz, R. L., & Bergman, R. N. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.03.008 · Cited by 3
Self-citationOsei, K., & Gaillard, T. R. (2018) · Journal of the National Medical Association · doi:10.1016/j.jnma.2018.06.004 · Cited by 3
Faraj, M. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30042-2 · Cited by 6
Ren, S., Wu, D., & Li, P. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117753 · Cited by 3
Yamamoto, Y., Ozamoto, Y., Kobayashi, M., Tezuka, Y., Azuma, C., Sekine, O., Ito-Kobayashi, J., Washiyama, M., Oe, Y., Iwanishi, M., et al. (2022) · Endocrine Journal · doi:10.1507/endocrj.ej21-0615 · Cited by 2
Kishimoto, I., & Ohashi, A. (2022) · Metabolites · doi:10.3390/metabo12111022 · Cited by 2
“It is reported that Sg and disposition index independently predict conversion to diabetes across various stages of glucose tolerance and obesity [15].”
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70163-2 · Cited by 3
L’hyperglycémie provoquée par voie orale (HGPO) revisitée
Scheen, A. J., & Luyckx, F. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70124-3 · Cited by 7
Nádasdi, Á., Gál, V., Masszi, T., Patócs, A., Igaz, P., Somogyi, A., & Firneisz, G. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00876-z · Cited by 2
Valdez, I. A., Palavicini, J. P., Bakewell, T. M., Fourcaudot, M. J., Ayala, I., Xu, Z., Khattab, A., Han, X., Shannon, C. E., & Norton, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.31.494168 · Cited by 3
“estimated β-cell function using the Disposition Index, which evaluates β-cell function relative to insulin sensitivity [38].”
Diagnosis and management of equine metabolic syndrome
Bertin, F. (2026) · Equine Veterinary Education · doi:10.1111/eve.70094 · Cited by 2
Le, M. H., Sam, H. S., Phạm, D. T., Nguyen, P. N., Le, N., & Dao, T. N. P. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e108879 · Cited by 1
“…resistance), HOMA-β (homeostatic model assessment of pancreatic β-cell function), QUICKI (quantitative insulin sensitivity check index), and DI (insulin disposition index), according to established guidelines (Muniyappa et al. 2000; Lorenzo et al. 2010; Onishi et al. 2010; Duan et al. 2019).”
Ionut, V., & Bergman, R. N. (2015) · Endocrine updates · doi:10.1007/978-1-4939-2146-1_1 · Cited by 1
Self-citationHinkley, J. M. (2016) · The Scholarship East Carolina University's Institutional Repository (East Carolina University)
Santaren, I. D. (2014) · TSpace (University of Toronto) · Cited by 1
Proposal for a New Oral Disposition Index with OGIS as a Marker of Insulin Action
Karina, A. (2017) · Endocrinology&Metabolism International Journal · doi:10.15406/emij.2017.05.00136
“Therefore, a low rate of DISPOSITION INDEX is an early marker of inadequate compensation of beta cells [4].”
Predictors of conversion from prediabetic state to type 2 diabetes mellitus in Jordan
Al-dajah, K., Al-Kassar, A., & Al‐Shdaifat, A. (2018) · Alexandria Journal of Medicine · doi:10.1016/j.ajme.2018.10.003 · Cited by 1
“In agreement with these findings, several studies reported associated factors related to conversion from pre-diabetes to T2DM.”
InfluentialTHE RELATIONSHIP BETWEEN DIFFERENT DIABETIC FACTORS IN IMPAIRED FASTING PLASMA GLUCOSE OBESE ELDERLY
Ma, M., & Pei, D. (2021) · GLOBAL JOURNAL FOR RESEARCH ANALYSIS · doi:10.36106/gjra/0107439
(2011) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283457c7d
Watanabe, R. M., & Hansen, T. F. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_9
Kojima, F., Morishita, S., Uda, S., Yutsudo, N., Ogawa, Y., & Kubota, H. (2025) · PLoS ONE · doi:10.1371/journal.pone.0337739 · Cited by 1
“Previous studies have suggested that glucose effectiveness plays an important role in the development of impaired glucose tolerance and is an important determinant of the progression of type 2 diabetes mellitus (T2DM) [9,10].”
Metabolic outcomes at 12 months postpartum among individuals with glucose intolerance in pregnancy
Scifres, C., Sinha, A., Orris, S. R., COSTACOU, T., Lalama, C. M., Abebe, K. Z., Catalano, P. M., & Davis, E. M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag035
Chen, Y., Lin, Y., Wang, L., Lee, C. L., Su, S., Lu, C.-H., Li, P., Huang, C., Ho, L.-J., Lin, M., et al. (2026) · Nutrition and Diabetes · doi:10.1038/s41387-026-00422-0 · Cited by 1
“Insulinogenic index and deposition index (Matsuda index × Insulinogenic index) were applied to evaluate fi rst-phase insulin secretion and glucose disposal [20].”
Aimaretti, G., Avogaro, A., Buzzetti, R., Candido, R. D., Colao, A., Fadini, G. P., Luzi, L., Morviducci, L., Napoli, N., & Giustina, A. (2026) · Journal of Endocrinological Investigation · doi:10.1007/s40618-026-03026-8
Aguilera‐Rodríguez, R., Almaguer‐Gotay, D., Sosa, A. Á., Anidos-Machado, M., Silva-Ricardo, Y., Cuello‐Almarales, D., Estupiñán‐Rodríguez, A., & Almaguer‐Mederos, L. E. (2026) · The Cerebellum · doi:10.1007/s12311-026-02076-1
Metadata
- Authors
- Lorenzo, C., Wagenknecht, L. E., Rewers, M. J., Karter, A. J., Bergman, R. N., Hanley, A. J. G., & Haffner, S. M.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Wake Forest University Health Sciences (US)
- University of Colorado Health (US)
- Kaiser Permanente (US)
- University of Southern California (US)
- Mount Sinai Hospital (CA)
- Baylor College of Medicine (US)
- Corresponding author
- Lorenzo, Carlos
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-09-01
- Volume
- 33
- Issue
- 9
- Pages
- 2098-2103
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2928371
- OpenAlex
- W2023961601
- Cited by
- 145
- References
- 25
- Citations by year
- 2026: 6 · 2025: 6 · 2024: 7 · 2023: 11 · 2022: 7 · 2021: 14 · 2020: 10 · 2019: 11 · 2018: 10 · 2017: 11 · 2016: 9 · 2015: 8 · 2014: 16 · 2013: 5 · 2012: 5
- FWCI
- 4.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- National Institutes of Health (5u01hl047890-09, 5u01hl047887-09, 5u01hl047889-09)
- National Heart, Lung, and Blood Institute (U01HL047902, HL-47889, HL‐47890, HL47887, U01HL047892, HL 47892)
- National Institute of Diabetes and Digestive and Kidney Diseases (R37DK027619, R01DK081796, R01DK029867)
- National Center for Research Resources (M01RR01346, M01RR001346, M01-RR431)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- disposition index, glucose effectiveness, insulin sensitivity, acute insulin response, type 2 diabetes, diabetes risk prediction, insulin resistance, insulin sensitivity index, new-onset diabetes, glucose tolerance, obesity, family history of diabetes
- MeSH terms
- Adult, Aged, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Male, Middle Aged, Risk Factors, Glucose Intolerance
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.